In a pragmatic trial conducted in general medical wards with limited diagnostic and therapeutic resources in Kenya, glucocorticoids reduced mortality in patients with community-acquired pneumonia. Full SONIA trial results: nej.md/47glh02 #MedSky #PulmSky #CriticalCare

Our team wore blue for World Antimicrobial Awareness Week 2025💙 Research into how resistance emerges, spreads and can be prevented is vital. Our group works to understand these processes and develop better tools to detect, monitor and combat antimicrobial resistance. #WAAW @oxfordbrc.bsky.social

Are you interested in infections, the micro-organisms that cause them and antimicrobial resistance? So are @bashthebug.net and they're looking for new members to join their patient & public group. More info: bashthebug.net/lay-represen... Deadline 27 Nov @ouhospitals.bsky.social @medsci.ox.ac.uk

Our recent paper on rifampicin resistant subpopulations in M. tuberculosis (M. tb) has been published at JAC-antimicrobial resistance. I am really happy to see this work published just hours before submitting my DPhil thesis! 🔗👇 doi.org/10.1093/jaca...

The @kemriwellcome.bsky.social Vaccine Workforce Development Programme, funded by the Gates Foundation, has partnered with BioGeneric Pharma in Cairo, Egypt, with support from the Egyptian Drug Authority to deliver a 12-week programme for apprentices selected from across Africa.

Now published in @natcomms.nature.com 🎉 www.nature.com/articles/s41... With Gillian Rodger, @nstoesser.bsky.social, @samlipworth.bsky.social, @stat-sarah.bsky.social, and many others!

🧪 ♻️ Want to make lab and computational research more sustainable? Check out our Oxford Climate Society blog post: oxfordclimatesociety.com/blog/from-pi... Shout out to Green Team colleagues @modmedmicro.bsky.social for helping! #LEAFAward #GreenDiSC #GreenImpact #SustainableScience

From Pipettes to Pipelines: Greening a Multidisciplinary Research Lab. @dotnagy.bsky.social writes about the experiences from the Modernising Medical Microbiology (MMM) research group on engaging wet lab, computer lab, and office teams on the #sustainability agenda. #GreenLab #SustainableScience

From Pipettes to Pipelines: Greening a Multidisciplinary Research Lab. @dotnagy.bsky.social writes about the experiences from the Modernising Medical Microbiology (MMM) research group on engaging wet lab, computer lab, and office teams on the #sustainability agenda. #GreenLab #SustainableScience

Pleased to see this pre-printed, highlighting the completeness/accuracy of @nanoporetech.com long-read genome assembly for clinical Enterobacterales: www.biorxiv.org/content/10.1... Thanks to colleagues @modmedmicro.bsky.social, @ukhsa.bsky.social, @genewiz.bsky.social and @oxfordbrc.bsky.social!

🩸 Every year, 400,000 children are born with Sickle Cell Disease (SCD) — most in Africa. 🇰🇪 In Kenya, 1 in 100 babies (~4,000 annually) is born with SCD. 💡Research is improving survival, with more reaching adulthood. #SickleCellAwarenessMonth 📚 Read more here : shorturl.at/86mTt

Shout out to @lou-downs.bsky.social & Dorcas Okanda for a prize at #COLDA. Their #HBV work in #Kenya expands insights in a neglected space, using #virus #genomics to influence healthcare. #MedSky #NoHep @crick.ac.uk @ndm.ox.ac.uk @ucl.ac.uk @wellcometrust.bsky.social @kemriwellcome.bsky.social 🧪🇰🇪🌍

Job opportunity for microbial genomicists interested in E. coli and Klebsiella infections and AMR 👀⬇️ - do get in touch if you might be interested! Closing date 7th Oct.

Sounds great that a journal wants to train peer reviewers. But it looks like this is an option for those of us who already do the reviewing for free to add the task of inviting trainees that we select, and supervise their peer review, again for free.

We are excited for the Oxford Tropical Network Meeting #OTN2025! A space for collaboration, innovation, and advancing global health. 📌 Theme : Networking for science discovery and impact 🗓️ Dates : Sept 16th – 18th, 2025 @ox.ac.uk @wellcometrust.bsky.social @ndm.ox.ac.uk @tropicalmedicine.ox.ac.uk

Join us as Head of Data Engineering & Informatics and help shape the future of infectious disease research. Apply today 🔗 www.iddo.org/about-us/jobs Deadline Sep 17 at noon @tropicalmedicine.ox.ac.uk @ox.ac.uk

📢 New research from Oxford AMR/HCAI HPRU: We applied an EHR-wide association study to uncover risk factors for E. coli bloodstream infections over 6 years 🧠 Frailty-related factors (renal/UTI, cancer, GI) drive risk 🛠️ Highlights need for multifaceted prevention strategies doi.org/10.1016/j.ji...

New analysis from Kevin Chau @modmedmicro.bsky.social for the SinkBug Consortium (a collaboration with teams across 29 UK hospitals, NITCAR, UKHSA): Pathogen and AMR gene burden in 287 hospital sink-trap metagenomes and factors associated with high burdens.

I don't find a lot in the Spectator that I like to read, but found this thought provoking and moving: www.spectator.co.uk/article/i-wo...

A new study by KEMRI Wellcome, @isglobal.org and the Manhiça Health Research Centre has highlighted that alongside bed nets, ivermectin reduced #malaria infection by 26% in children. Their findings show that it's a valuable tool for tackling the spread of malaria 🦟💊 Read more 👉 buff.ly/0OU6UhJ

Job advert to come and work with me on tuberculosis closes tomorrow (Friday) at noon! Part of #OxCOD4TB bit.ly/4ndKOhF @ndm.ox.ac.uk @modmedmicro.bsky.social @oxfordbrc.bsky.social

Come and work with us! Senior Biostatistical Researcher bit.ly/4kRfZxI Senior Bioinformatic Engineer bit.ly/4ecl0hF both Grade 8 or 7, closing noon Tue 8 Jul Computational Mycobacteriologist Grade 7, closing noon Fri 4 Jul bit.ly/4ndKOhF @medsci.ox.ac.uk @oxfordbrc.bsky.social @ndm.ox.ac.uk

Nice data. To me the coolest, tho also most alarming, is slope of antibiotic resistance declining over time - gradient is shallow! So that means if UTIs recur frequently, you can see how you burn through antibiotic options quickly! #UTISky #IDSky #ClinMicro #AMR academic.oup.com/jac/advance-...

Come and work with me and use the 53,897 samples of M. tuberculosis we have collated to help tackle this important disease! We are part of the OxCoD4TB consortium that is developing new therapeutics for tuberculosis. Grade 7, funding until 28 Feb 2028, deadline noon Fri 4 July bit.ly/4ndKOhF

Come & work with me @benvyle.bsky.social @lshtm.bsky.social & @thelovetankcic.bsky.social Research Assistant with funded PhD within multidisciplinary project on Syphilis & STI control in the UK. Working with us to understand stakeholder & community perspectives on novel STI control strategies

The relaunch of crypticproject.info at #ESMyco by @philipwfowler.bsky.social 53,897 clinical tuberculosis samples with genetics and drug susceptibility testing data!

@vbrunner.bsky.social doing her pitch for her poster at #ESMyco! @modmedmicro.bsky.social

Come and help us develop and validate genetic pipelines for processing pathogens in collaboration with @eitoxford.bsky.social Senior Bioinformatic Engineer bit.ly/4ecl0hF Senior Biostatistical Researcher bit.ly/4kRfZxI Grade 8 or 7, depending on experience closing date: noon Wednesday 2 July

Just like buses, here is a third role we are advertising for! Come and help @philipwfowler.bsky.social use the large TB datasets we hold to help the OxCoD4TB consortium develop new therapeutics for tuberculosis. Grade 7, funding until 28 Feb 2028, deadline noon Fri 4 July bit.ly/4ndKOhF

Come and help us develop and validate genetic pipelines for processing pathogens in collaboration with @eitoxford.bsky.social Senior Bioinformatic Engineer bit.ly/4ecl0hF Senior Biostatistical Researcher bit.ly/4kRfZxI Grade 8 or 7, depending on experience closing date: noon Wednesday 2 July

New preprint! Deacon is a versatile tool for filtering FASTA/FASTQ files and streams at hundreds of megabases per second using minimizers, built with rapid metagenomic host depletion in mind, but equally useful for search. github.com/bede/deacon

🆕What happens when humanitarian aid is cut or delayed? A 20% aid cut in one of the world's largest refugee camp didn’t just reduce what and how much refugees eat; it also triggered a cascade of effects across households and markets. voxdev.org/topic/instit... with Vittorio Bruni and @wfp.org

We are looking for a highly motivated postdoc to work on pathogen interactions. Please send in your application via jobs.uzh.ch/job-vacancie...

Vaccines are powerful. But we’re missing a chance to use them to tackle antimicrobial resistance (AMR). Our latest report examines how they can reduce AMR and where more evidence is needed to guide policy. Read the report: wellcome.org/reports/vacc...

Come and play our dance mat game named after me! Outside John Lewis in the Westgate as part of the @oxfordbrc.bsky.social showcase!

Come and find @modmedmicro.bsky.social at the Westgate in Oxford as part of the @oxfordbrc.bsky.social showcase!

Lots of bugs at the @oxfordbrc.bsky.social showcase in the Westgate!

Looping out bacteria (well couscous) is harder than it looks! @oxfordbrc.bsky.social @modmedmicro.bsky.social

Excited to share 9 fully funded PhD projects with NIHR HPRU Public Health genomics at UKHSA and University of Birmingham. Deadline 31 July www.birmingham.ac.uk/research/cen... Ranging from methods development, microbiome, metagenomics and species specific (TB, Strep pneumo, measles) projects

🆕🌟Super interesting! The study challenges IDSA guidance which recommend against the use of CAZ for treatment of S.maltophilia Ceftazidime retains in vivo efficacy against strains of Stenotrophomonas maltophilia for which traditional testing predicts resistance #idsky journals.asm.org/doi/10.1128/...

Interested in T cell immunity in TB? Check out our new pre-print on antigen-agnostic identification of generalisable human in vivo Mtb-reactive T cell responses: www.biorxiv.org/content/10.1... with @qimmuno.bsky.social & @innate2adaptive.bsky.social

My father-in-law, Jack Strominger, and I wrote a letter to the @wsj.com editor about the current threats to science due to Trump's funding freeze. Please repost! www.wsj.com/opinion/scie...

A timely example of why we should do trials of interventions rather than just use them in an observational fashion even for most emerging infections. I hope this will alter approach to to use in UK.

Thrilled to have returned to the Congress of @escmid.bsky.social this year in the beautiful city of Vienna, and to have had the opportunity to present my latest work on rifampicin-resistant subpopulations in M. tuberculosis. 📋 Find all the details in our preprint: 🔗👇 www.biorxiv.org/content/10.1...

Kevin Yuan talking now at #ESCMIDGlobal in Hall 9!

@junkotakata.bsky.social presenting her poster at #ESCMIDGlobal!

…and Valentina Pennetta presenting her poster! With MICs for 38 ABX for each sample 😱

@vbrunner.bsky.social talking at #ESCMIDGlobal !

Dylan Adlard, Jeremy Westhead and me presenting posters in the huge hall at #ESCMIDGlobal

Another busy day at #ESCMIDGlobal! 0906 @vbrunner.bsky.social “RIF and subpopulations in TB” 0918 Ruan Spies “comparing TB pipelines" both in Hall 5 1000 Nicole Stoesser “plasmids & 1Health” in H2 1509 Jane Wei in Hall 2 “CAP and EHR” P1405 - Valentina Pennetta P2242 - Junko Takada